Endocrinology

Top Story

High normal range atrial natriuretic peptide may reduce insulin resistance risk in middle age

February 12, 2016

Exposure during middle age to atrial natriuretic peptide within the high normal range appears to be associated with a reduced risk for insulin resistance after 16.5 years of follow-up.

Amra Jujić, PhD, of the department of cardiology at Skane University Hospital in Sweden, and colleagues evaluated data from the Malmö Diet and Cancer Study cardiovascular cohort on 2,243 patients without diabetes. An immunoluminometric sandwich assay was used to measure midregional pro-atrial natriuretic peptide (MR-proANP). At 16.5 years of follow-up, an oral glucose tolerance test was used to measure glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1, insulin, glucose and glucagon.

Senate Health Committee passes Advancing Research for Neurological Diseases Act of 2015

February 12, 2016
The Senate Health Committee passed the “Advancing Research for Neurological Diseases Act of 2015” (S. 849)” on Tuesday, which will establish a national…
In the Journals

Obesity hypoventilation syndrome often misdiagnosed, affecting mortality

February 12, 2016
Many patients with obesity hypoventilation syndrome are misdiagnosed as having other respiratory conditions and receive inappropriate therapy, likely contributing to a…
In the Journals

Text message support may yield significant weight loss in prediabetes

February 12, 2016
In patients with prediabetes, the use of text message support may be conducive to clinically significant weight loss, according to study findings published in Diabetes

Senate health committee passes Next Generation Researchers Act

February 12, 2016
The Senate health committee passed the Next Generation Researchers Act (S. 2014) with bipartisan support on Tuesday, which aims to increase opportunities for young…
More News Headlines »
CME

Managing Today's EP Challenges with NOAC Use

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Daiichi Sankyo, Inc.

This engaging activity featuring a superb faculty provides electrophysiologists and others with the best information…
More »
Meeting News CoverageVideo

VIDEO: Weight loss tips from the experts — Better sleep means better weight loss

November 25, 2015
More »
Featured
CME

Real-world Use of Anti-VEGF Therapy

This activity is supported by an educational grant from Genentech, Inc.

Anti-VEGF is well established as first-line therapy for the treatment of diabetic macular edema (DME) and age-related…
More »
Current Issues
View the Current Issues
morganatic-roan